1.
Hakimian M, Noori R. The relationship between Pembrolizumab for the treatment of PD-L1 positive advanced in cell lung cancer. Int Pharm Acta [Internet]. 2018 Mar. 4 [cited 2024 May 3];1(1):154-. Available from: https://journals.sbmu.ac.ir/acta/article/view/20499